Q95153 AF NFT

Breast cancer type 1 susceptibility protein homolog

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeigp4zjzszt3go7sgmxu3gxrqu62ygr7yxjoeecfdqhdkiln7cqhma/metadata.json
IPFS of structure file: 
bafybeighz6e7yhgahg2dlfhnpqawifg2xxu5tlnjdyjcdcok6lj6nnxsqm/AF-Q95153-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xa4c1cb262579E9bA578f7bEf2fca986dddAA715E
First NFT owner address (bech32): 
genesis15nqukf39085m54u000hjlj5cdhw65u277ppkh5
Current NFT ID #46111 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1_w

NFT id:
46111
Accession (UniProt):
Q95153
Name::
Breast cancer type 1 susceptibility protein homolog
Experimental Method:
Predicted structure
Sequence source:
CANIS LUPUS FAMILIARIS

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT Q95153 research and analysis (ICN3D with VR)

FASTA sequences

>sp|Q95153|BRCA1_CANLF Breast cancer type 1 susceptibility protein homolog OS=Canis lupus familiaris OX=9615 GN=BRCA1 PE=3 SV=1 MDLSADRVEEVQNVLNAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQRKGPSQCPLCKNDITKRSLQESTRFSQLVEELLKIIHAFELDTGLQFADSYNFSKKENNSPEHLKEEVSIIQSMGYRNRAKRLRQSEPENPTLETSLSVQLSNLGIVRSLRTKQQIQPQNKSVYIELGSDSSEDTVNKASSCSVGDDELEITSQGARAEASLNPAKKAACEFSGDITNIEHHQSSNKDLTTTEKHATKKHPEKYQGISVSNLHVEPCGTNTHASSLQHENSSLLLTKHRMNVEKAEICNNSKQPGLARSQQSRWAESKETCNDRQIPSTEKKVVVNADLLCGRKELNKQKPPHSDSPRDSQDVPWITLNSSIRKVNEWFSRSDEILTSDDSHDRGSELNTEVGGAVEVPNEVGEYSGSSEKIDLMASDPQDAFICESERVHTKPVGGNIEDKIFGKTYRRKASLPKVSHTTEVLTIGACAIEPQTMQTHPFMNKAEHKRRTTSSLHPEDFIKKVELGIVPKTPEKLIEGINQIKRDGHVINITNNGPENETEGDYVQKEKNANPTESLEKESAFRTKTEPMSSRISNMELELNSSSSKAPKKNRLRRKSSARHTCALEFVVNRNLNPPDHSELQIESCSSSEEMKKQHLDQVPVRHNKTLQLMQDKEPAGRAKKSSKPGEQINKRLASHAFPELTLTNVSGFFANYSSSSKPQECINPGLRREEIEESRRMTQVSDSTRDPKELVLSGGRGLQTERSVESTSISLVLDTDYGTQDSISLLEADTLRKAKTVSNQQANLCATIENPKEPIHGCSKDTRNDTEGFVVPLTCKDNHTQETSIEMEESELDTQCLRNMFKVSKRQSFALFSYPRDPEEDCVTVCPRSGAFGKQGPKVTLECGQKEESQGKKESEIRHVQAVHTNAGFSAVSQKAKKPGDFAKCSIKGVSRLCLSSQFKGKETELLIANYHGISQNPYHIPPLSPIRSCVKTLCQENLSEEKFEQHSMSPERAVGNERVIQSTVSTISQNNIRECASKEVGSSSVNEVVSSTNEVGSSVNEVGSSGENIQAELGRNRGPKLNAMLRLGLMQPEVCKQSLSLSNCKHPEMKWQGQSEGAVLSVSADFSPCLISDNPEQPMGSSRSSQVCSETPDDLLNGDKIKGKVSFAESDIKEKSAVFSKSVQSGEFSRSPSPSDHTRLAQGYQRGTKKLESSEENMSSEEEELPCFQHLIFGKVTNMPSQSTSHNAVAAEGLSNKTEENLDSLKNSLSDISNQVPSAKASQEHHLSEEARCSGSLFSSQCSALEDLTVNTNTQDPFSMFDPTSKQVRHQSENLDVLNDKELVSDDDDEREPGLEEDSPQEEQSVDSDLGEVASGYESETSLSEDCSRLSSQSDILTTQQRDTMQDNLIKLQQEMAELEAVLEQHESQPSNSSPSLIADSCSPEDLLNPEQNASERVLTSEKSSDSPISQNPESLSTDKFQVFLDSSTSKNGEPGMIRSSPSQSRLLDTRWYVHSCPRSLQDTNCPSQKELTKVVSMEEQQPTESEARDLMEQSYLSRPDLEGAPYLESGISLFSDDPESDPSSHRASELAHVSSMPTSTSALKLPQFQVEESAKSTAAVHIASTAGYNKSEDSVGIEKPEVISSTRGVNKRISMVASGLTPKEFMLVHKFARKHHISLTNLISEETTHVIMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKILDEHDFEVRGDVVNGRNHQGPKRARESQDRESQDRKIFRGLEICCYGPFTNMPTDQLEWMVHLCGASVVKEPSLFTLSKGTHPVVVVQPDAWTEDSGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPRTAADSSQPCV